GB Sciences, Inc.
(OTC:GBLX)
Company Description:
On March 18, 2014, GBLX purchased assets from Craig Ellins, which included the proprietary GrowBlox tech.
They plan to utilize this technology to commercially cultivate and produce medical grade cannabis for sale in the U.S. states and territories in which it is legal. GBLX also plans to research the medical treatment potential of cannabis and develop treatments from those findings. On April 4, 2014, GBLX officially changed their name to GrowBLOX Sciences, Inc. to reflect its new corporate direction.
